<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02623140</url>
  </required_header>
  <id_info>
    <org_study_id>SORT OUT IX</org_study_id>
    <nct_id>NCT02623140</nct_id>
  </id_info>
  <brief_title>BIOFREEDOM Stent Versus ORSIRO Stent: SORT OUT IX</brief_title>
  <acronym>SORT OUT IX</acronym>
  <official_title>Randomized Comparison of a Polymer-Free Biolimus-eluting BIOFREEDOM Stent With a Biodegradable-Polymer Sirolimus-eluting ORSIRO Stent in Patients Treated With Percutaneous Coronary Intervention</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Odense University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Aarhus University Hospital Skejby</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Aalborg Universitetshospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Rigshospitalet, Denmark</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Odense University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of the Danish Organization for Randomized Trials with Clinical Outcome (SORT OUT) is
      to compare the safety and efficacy of the polymer-free Biolimus-eluting BIOFREEDOM stent with
      a biodegradable-polymer Sirolimus-eluting ORSIRO stent in a population-based setting, using
      registry detection of clinically driven events
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      SORT OUT IX is a randomized, multicenter, all-comer, two-arm, non-inferiority trial comparing
      the polymer-free Biolimus-eluting BIOFREEDOM stent with a biodegradable-polymer
      Sirolimus-eluting ORSIRO stent in treating atherosclerotic coronary artery lesions.

      Patients will be enrolled by the investigators and randomly allocated to treatment groups
      after diagnostic coronary angiography and before percutaneous coronary intervention. Block
      randomization by centre (permuted blocks of random sizes (2/4/6)) will be used to assign
      patients in a 1:1 ratio to receive the polymer-free Biolimus-eluting BIOFREEDOM stent
      (Biosensors) or the biodegradable-polymer Sirolimus-eluting ORSIRO stent (Biotronik). A web
      based Trial Partner randomization system will be used.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>December 2015</start_date>
  <completion_date type="Anticipated">October 2021</completion_date>
  <primary_completion_date type="Anticipated">October 2017</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Target Lesion Failure</measure>
    <time_frame>12 months</time_frame>
    <description>Primary endpoint assessed after 12 months</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Target lesion failure</measure>
    <time_frame>2 year, 3 year, 4 year, 5 year</time_frame>
    <description>Target lesion failure will be assessed yearly up to 5 years after index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stent thrombosis</measure>
    <time_frame>1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Stent thrombosis will be assessed yearly up to 5 years after index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial infarction</measure>
    <time_frame>1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Myocardial infarction will be assessed yearly up to 5 years after index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac death</measure>
    <time_frame>1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Cardiac death will be assessed yearly up to 5 years after index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>All cause mortality</measure>
    <time_frame>1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>All cause mortality will be assessed yearly up to 5 years after index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target lesion revascularization</measure>
    <time_frame>1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Target lesion revascularization will be assessed yearly up to 5 years after index procedure</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Target vessel revascularization</measure>
    <time_frame>1 year, 2 years, 3 years, 4 years, 5 years</time_frame>
    <description>Target vessel revascularization will be assessed yearly up to 5 years after</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">3150</enrollment>
  <condition>Ischaemic Heart Disease</condition>
  <arm_group>
    <arm_group_label>Biofreedom</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Biofreedom stent treatment at index procedure</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Orsiro</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Orsiro stent treatment at index procedure</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Biofreedom</intervention_name>
    <description>PCI with Biofreedom stent</description>
    <arm_group_label>Biofreedom</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Orsiro</intervention_name>
    <description>PCI with Orsiro stent</description>
    <arm_group_label>Orsiro</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients aged 18 years or over with chronic stable coronary artery disease or acute
             coronary syndromes, and at least one coronary artery lesion with more than 50%
             diameter stenosis, requiring treatment with a drug-eluting stent.

        Exclusion Criteria:

          -  Life expectancy of less than one year; an allergy to aspirin, clopidogrel, ticagrelor,
             prasugral, biolimus or sirolimus; participation in another randomized trial; or
             inability to provide written informed consent.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lisette Okkels Jensen, MD DMSci PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Odense University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Evald H Christiansen, MD PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Aarhus University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Odense University Hospital</name>
      <address>
        <city>Odense</city>
        <zip>5000</zip>
        <country>Denmark</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Denmark</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 30, 2015</study_first_submitted>
  <study_first_submitted_qc>December 2, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 7, 2015</study_first_posted>
  <last_update_submitted>April 23, 2017</last_update_submitted>
  <last_update_submitted_qc>April 23, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 25, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Odense University Hospital</investigator_affiliation>
    <investigator_full_name>Lisette Okkels Jensen</investigator_full_name>
    <investigator_title>MD DMSci PhD</investigator_title>
  </responsible_party>
  <keyword>Coronary drug eluting stents</keyword>
  <keyword>Outcomes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

